Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 4
2009 1
2012 1
2013 2
2014 5
2015 3
2016 1
2017 1
2018 4
2019 5
2020 5
2021 6
2022 10
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean gao cong li (9 results)?
TIMM44 is a potential therapeutic target of human glioma.
Guo YZ, Chen G, Huang M, Wang Y, Liu YY, Jiang Q, Cao C, Liu F. Guo YZ, et al. Among authors: cao c. Theranostics. 2022 Oct 31;12(17):7586-7602. doi: 10.7150/thno.78616. eCollection 2022. Theranostics. 2022. PMID: 36438483 Free PMC article.
Neuronal-driven glioma growth requires Gαi1 and Gαi3.
Wang Y, Liu YY, Chen MB, Cheng KW, Qi LN, Zhang ZQ, Peng Y, Li KR, Liu F, Chen G, Cao C. Wang Y, et al. Among authors: cao c. Theranostics. 2021 Jul 25;11(17):8535-8549. doi: 10.7150/thno.61452. eCollection 2021. Theranostics. 2021. PMID: 34373757 Free PMC article.
Effect of flexible sigmoidoscopy-based screening on colorectal cancer incidence and mortality: an updated systematic review and meta-analysis of randomized controlled trials.
Zhang C, Liu L, Li J, Lv Y, Wu D, Xu S, Cao C, Zhao L, Liu Y, Ma X, Yang X, Du B. Zhang C, et al. Among authors: cao c. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(11):1217-1227. doi: 10.1080/14737140.2023.2245564. Epub 2023 Aug 8. Expert Rev Anticancer Ther. 2023. PMID: 37542427 Review.
RMI2 is a novel prognostic and predictive biomarker for breast cancer.
Zhang L, Hao C, Han B, Zeng G, Han L, Cao C, Liu H, Zhong Z, Zhao X, Wang J, Zhang Q. Zhang L, et al. Among authors: cao c. Cancer Med. 2023 Apr;12(7):8331-8350. doi: 10.1002/cam4.5533. Epub 2022 Dec 19. Cancer Med. 2023. PMID: 36533385 Free PMC article.
56 results